galantamine and rs 67333

galantamine has been researched along with rs 67333 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guillou, C; Lamirault, L; Simon, H; Thal, C1
Boulouard, M; Dauphin, F; Freret, T; Hamidouche, K; Lecouflet, P; Lelong-Boulouard, V1

Other Studies

2 other study(ies) available for galantamine and rs 67333

ArticleYear
Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2003, Volume: 27, Issue:1

    Topics: Age Factors; Aniline Compounds; Animals; Cholinesterase Inhibitors; Drug Therapy, Combination; Galantamine; Injections, Intraperitoneal; Male; Memory; Pattern Recognition, Automated; Piperidines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Task Performance and Analysis

2003
Co-modulation of an allosteric modulator of nicotinic receptor-cholinesterase inhibitor (galantamine) and a 5-HT4 receptor agonist (RS-67333): effect on scopolamine-induced memory deficit in the mouse.
    Psychopharmacology, 2017, Volume: 234, Issue:15

    Topics: Allosteric Regulation; Alzheimer Disease; Aniline Compounds; Animals; Cholinesterase Inhibitors; Galantamine; Male; Memory Disorders; Mice; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Receptors, Serotonin, 5-HT4; Scopolamine; Serotonin 5-HT4 Receptor Agonists

2017